A detailed history of Stonegate Investment Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Stonegate Investment Group, LLC holds 78,794 shares of ABT stock, worth $9.23 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
78,794
Previous 78,688 0.13%
Holding current value
$9.23 Million
Previous $8.18 Million 9.87%
% of portfolio
0.24%
Previous 0.24%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$100.07 - $118.13 $10,607 - $12,521
106 Added 0.13%
78,794 $8.98 Million
Q2 2024

Aug 02, 2024

SELL
$100.73 - $112.44 $133,970 - $149,545
-1,330 Reduced 1.66%
78,688 $8.18 Million
Q1 2024

Apr 22, 2024

BUY
$109.52 - $120.96 $251,019 - $277,240
2,292 Added 2.95%
80,018 $9.09 Million
Q4 2023

Jan 23, 2024

SELL
$90.19 - $110.4 $700,866 - $857,918
-7,771 Reduced 9.09%
77,726 $8.56 Million
Q3 2023

Oct 24, 2023

SELL
$95.53 - $114.62 $80,722 - $96,853
-845 Reduced 0.98%
85,497 $8.28 Million
Q2 2023

Jul 26, 2023

BUY
$100.78 - $112.29 $4,938 - $5,502
49 Added 0.06%
86,342 $9.41 Million
Q1 2023

Apr 20, 2023

BUY
$96.86 - $114.01 $5.51 Million - $6.48 Million
56,868 Added 193.26%
86,293 $8.74 Million
Q4 2022

Jan 24, 2023

SELL
$95.06 - $111.52 $16,160 - $18,958
-170 Reduced 0.57%
29,425 $0
Q3 2022

Oct 28, 2022

BUY
$96.76 - $112.03 $497,926 - $576,506
5,146 Added 21.05%
29,595 $2.86 Million
Q2 2022

Aug 09, 2022

BUY
$102.07 - $123.37 $1.97 Million - $2.38 Million
19,328 Added 377.43%
24,449 $2.66 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $9,805 - $11,957
-86 Reduced 1.65%
5,121 $606,000
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $601,564 - $736,582
5,207 New
5,207 $733,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Stonegate Investment Group, LLC Portfolio

Follow Stonegate Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonegate Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonegate Investment Group, LLC with notifications on news.